Responses
Regular and Young Investigator Award Abstracts
Other
898 Intratumoral administration of NL-201, an alpha-independent IL-2/15 receptor agonist, inhibits the growth of both injected and uninjected tumors in preclinical models
Compose a Response to This Article
Other responses
No responses have been published for this article.